{"transactions":[{"id":706427,"issuer":{"id":6713,"kind":"organization","name":"PolyPid Ltd."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-07-17T20:03:04.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":9132,"price":4.46,"value":40728.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest on a quarterly basis beginning July 15, 2026 until April 15, 2030."}],"balance_after":9132,"derivative":{"exercise_price":4.46,"exercise_date":"2026-10-15","expiration_date":"2036-07-15","underlying":"Ordinary Shares","underlying_shares":9132},"source":{"system":"sec-edgar","filing":"0001213900-26-079158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1597158/000121390026079158/ownership.xml","form_type":"4"}},{"id":1557782,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2024-03-30T01:29:23.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":1.74,"value":130500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable."}],"balance_after":75000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-03-25","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-012073","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224012073/ownership.xml","form_type":"4"}},{"id":1888733,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-05-17T22:26:21.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":10365,"price":5.9457,"value":61627.1805,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein."}],"balance_after":317803,"source":{"system":"sec-edgar","filing":"0001376339-23-000031","document":"wf-form4_168436236626701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000031/wf-form4_168436236626701.xml","form_type":"4"}},{"id":1888732,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-05-17T22:26:21.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":3607,"price":6.1465,"value":22170.4255,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein."}],"balance_after":328168,"source":{"system":"sec-edgar","filing":"0001376339-23-000031","document":"wf-form4_168436236626701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000031/wf-form4_168436236626701.xml","form_type":"4"}},{"id":1894883,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-05-12T22:56:06.000Z","date":"2023-05-10","kind":"sale","planned":false,"acquired":false,"shares":5869,"price":5.9261,"value":34780.2809,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting."}],"balance_after":331775,"source":{"system":"sec-edgar","filing":"0001376339-23-000028","document":"wf-form4_168393215769457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000028/wf-form4_168393215769457.xml","form_type":"4"}},{"id":1899369,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-05-09T12:32:56.000Z","date":"2023-05-04","kind":"sale","planned":false,"acquired":false,"shares":51756,"price":5.3418,"value":276470.2008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $5.125 to $5.540, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":337644,"source":{"system":"sec-edgar","filing":"0001376339-23-000022","document":"wf-form4_168363556235229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000022/wf-form4_168363556235229.xml","form_type":"4"}},{"id":1912190,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-04-27T23:24:40.000Z","date":"2023-04-25","kind":"sale","planned":false,"acquired":false,"shares":5987,"price":3.744,"value":22415.328,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting."}],"balance_after":389400,"source":{"system":"sec-edgar","filing":"0001628280-23-013697","document":"wf-form4_168263786872653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000162828023013697/wf-form4_168263786872653.xml","form_type":"4"}},{"id":1920271,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-04-13T21:50:50.000Z","date":"2023-04-11","kind":"sale","planned":false,"acquired":false,"shares":5996,"price":3.31,"value":19846.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting."}],"balance_after":395387,"source":{"system":"sec-edgar","filing":"0001628280-23-011533","document":"wf-form4_168142263442757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000162828023011533/wf-form4_168142263442757.xml","form_type":"4"}},{"id":1952004,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-03-15T22:26:52.000Z","date":"2023-03-13","kind":"grant","acquired":true,"shares":135065,"price":4.62,"value":624000.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects grant of restricted stock units which will be settled in common stock following vesting.  Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3."}],"balance_after":401383,"source":{"system":"sec-edgar","filing":"0001376339-23-000007","document":"wf-form4_167891919545041.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000007/wf-form4_167891919545041.xml","form_type":"4"}},{"id":1960843,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2023-03-09T22:43:12.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":12355,"price":4.2446,"value":52442.033,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting."}],"balance_after":266318,"source":{"system":"sec-edgar","filing":"0001376339-23-000005","document":"wf-form4_167840178194084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633923000005/wf-form4_167840178194084.xml","form_type":"4"}},{"id":2159248,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-09-15T00:17:28.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":8329,"price":3.456,"value":28785.024,"ownership":{"direct":true},"balance_after":278673,"source":{"system":"sec-edgar","filing":"0001376339-22-000114","document":"wf-form4_166320103466747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000114/wf-form4_166320103466747.xml","form_type":"4"}},{"id":2159247,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-09-15T00:17:28.000Z","date":"2022-09-12","kind":"sale","acquired":false,"shares":19000,"price":3.436,"value":65284.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.42 to $3.45, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":287002,"source":{"system":"sec-edgar","filing":"0001376339-22-000114","document":"wf-form4_166320103466747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000114/wf-form4_166320103466747.xml","form_type":"4"}},{"id":2184012,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-08-16T22:49:42.000Z","date":"2022-08-12","kind":"sale","acquired":false,"shares":8503,"price":4.039,"value":34343.617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award."}],"balance_after":306002,"source":{"system":"sec-edgar","filing":"0001376339-22-000110","document":"wf-form4_166069016592798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000110/wf-form4_166069016592798.xml","form_type":"4"}},{"id":2191842,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-08-08T21:43:17.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":19500,"price":3.62,"value":70590.0,"ownership":{"direct":true},"balance_after":314505,"source":{"system":"sec-edgar","filing":"0001376339-22-000103","document":"wf-form4_165999497107897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000103/wf-form4_165999497107897.xml","form_type":"4"}},{"id":2218620,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-06-30T23:09:21.000Z","date":"2022-06-28","kind":"sale","acquired":false,"shares":14600,"price":3.47,"value":50662.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $3.47 to $3.48, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":334005,"source":{"system":"sec-edgar","filing":"0001376339-22-000095","document":"wf-form4_165663054650638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000095/wf-form4_165663054650638.xml","form_type":"4"}},{"id":2298295,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Regenerative Med."}}],"security":"Common Stock","published_at":"2022-04-12T21:24:48.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":178571,"price":4.62,"value":824998.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects grant of restricted stock units which will be settled in common stock following vesting.  Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3."}],"balance_after":348605,"source":{"system":"sec-edgar","filing":"0001376339-22-000038","document":"wf-form4_164979866808881.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000038/wf-form4_164979866808881.xml","form_type":"4"}},{"id":2339679,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2022-03-10T21:21:46.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":11672,"price":4.859,"value":56714.248,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":170034,"source":{"system":"sec-edgar","filing":"0001376339-22-000021","document":"wf-form4_164694725686210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633922000021/wf-form4_164694725686210.xml","form_type":"4"}},{"id":2599810,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-08-17T20:56:21.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":9362,"price":11.853,"value":110967.786,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares sold to pay associated taxes upon vesting."}],"balance_after":181706,"source":{"system":"sec-edgar","filing":"0001376339-21-000097","document":"wf-form4_162923376480953.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000097/wf-form4_162923376480953.xml","form_type":"4"}},{"id":2802903,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2021-03-08T21:17:27.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":109235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects grant of restricted stock units which will be settled in common stock following vesting.  Award vests pro rata annually over three years."}],"balance_after":191068,"source":{"system":"sec-edgar","filing":"0001376339-21-000006","document":"wf-form4_161523822300592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633921000006/wf-form4_161523822300592.xml","form_type":"4"}},{"id":3060058,"issuer":{"id":5271,"kind":"organization","name":"MIMEDX GROUP, INC."},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research and Development"}}],"security":"Common Stock","published_at":"2020-08-12T20:36:56.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":81833,"price":6.11,"value":499999.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock which vests one-third each anniversary."}],"balance_after":81833,"source":{"system":"sec-edgar","filing":"0001376339-20-000095","document":"wf-form4_159726459429104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376339/000137633920000095/wf-form4_159726459429104.xml","form_type":"4"}},{"id":3246918,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"PTIX Common stock Options","published_at":"2020-02-27T01:32:16.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As this was an option grant, there was no cost to the recipient."}],"balance_after":150000,"derivative":{"exercise_price":1.75,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"PTIX Common Stock, Par Value $0.0001","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-20-003043","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000149315220003043/ownership.xml","form_type":"4"}},{"id":4184192,"issuer":{"id":8496,"kind":"organization","name":"Protagenic Therapeutics, Inc.\\new"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":true}}],"security":"Non-Qualified Stock Options (Right to Buy()","published_at":"2017-10-18T18:23:30.000Z","date":"2017-10-16","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in equal installments over 18 months"}],"balance_after":200000,"derivative":{"exercise_price":1.75,"expiration_date":"2027-10-16","underlying":"Protagenic Therapeutics, Inc. Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-17-017235","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022899/000143774917017235/rdgdoc.xml","form_type":"4"}},{"id":4362499,"issuer":{"id":5774,"kind":"organization","name":"AGENUS INC","symbol":"AGEN"},"owners":[{"id":29686,"kind":"person","name":"Stein Robert Benjamin","position":1,"cik":"0001597158","reported_name":"Stein Robert Benjamin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President R&D"}}],"security":"Stock Option, Right to Buy","published_at":"2017-04-04T22:42:47.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":100000,"price":3.77,"value":377000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest one-third on the one-year anniversary of the grant date with the remainder vesting in equal quarterly installments provided the executive maintains a service relationship with the Company through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":3.77,"exercise_date":"2018-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001288123-17-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1098972/000128812317000013/primary_doc.xml","form_type":"4"}}]}